Trial intelligence / Profile preview

Genetic modulation of functional brain activity of ADHD-related working memory processes

2008-006242-26Phase 2Completed

Sponsor
University Hospital Würzburg
Start
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University Hospital Würzburg. Primary endpoint: Primary fMRI endpoint. Started Aug 2009; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on 2008-006242-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-006242-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call